16 October 2015 - In final draft guidance issued today NICE has recommended vortioxetine (Brintellix, Lundbeck) for some adults with major depressive disorder. The positive recommendation follows the submission of further evidence from the company that NICE requested in its previous draft guidance.

For more details, go to: http://www.nice.org.uk/news/press-and-media/nice-draft-guidance-recommends-vortioxetine-brintellix-for-treating-major-depressive-episodes